Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase III KEYNOTE-564 study von Choueiri, Toni K., Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Tom, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N., Lee, Jae-Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B., Sawrycki, Piotr, Zhang, Eric (Pingye), Willemann Rogerio, Jaqueline, Imai, Kentaro, Quinn, David I., Powles, Thomas

Volltext

KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cel... von Bratland, Åse, Muñoz-Couselo, Eva, Mortier, Laurent, Roshdy, Osama, Gonzalez, Rene, Schachter, Jacob, Arance, Ana Maria, Grange, Florent, Meyer, Nicolas, Joshi, Abhishek Jagdish, Billan, Salem, Hughes, Brett Gordon Maxwell, Grob, Jean-Jacques, Ramakrishnan, Karthik, Zhang, Eric (Pingye), Gumuscu, Burak, Swaby, Ramona F., Gutzmer, Ralf

Volltext

Abstract CT170: KEYNOTE-629: Phase II study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma von Grob, Jean-Jacques, Mendoza, Rene Gonzalez, Basset-Seguin, Nicole, Schachter, Jacob, Vornicova, Olga, Bauman, Jessica, Grange, Florent, Meyer, Nicolas, Piulats, Josep, Zhang, Pingye (Eric), Gumuscu, Burak, Swaby, Ramona, Hughes, Brett GM

Volltext

KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC) von Grob, Jean Jacques, Gonzalez, Rene, Basset-Seguin, Nicole, Schachter, Jacob, Vornicova, Olga, Bauman, Jessica Ruth, Grange, Florent, Meyer, Nicolas, Piulats, Josep M., Zhang, Eric (Pingye), Gumuscu, Burak, Swaby, Ramona F., Hughes, Brett Gordon Maxwell

Volltext

Dose Selection with 2-in-1 Design von Zhang, Eric (Pingye), Tang, Hui, Liu, Fang, Yang, Miao, Deng, Qiqi, Bai, Xiaofei, Huang, Xiaobi, Zhou, Heng, Ma, Haijun, Zhou, Yan, Ren, Xuehan

Volltext

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma von Choueiri, Toni K, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N, Lee, Jae Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B, Sawrycki, Piotr, Gurney, Howard, Chevreau, Christine, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Burke, John M, Doshi, Gurjyot, Topart, Delphine, Oudard, Stephane, Hammers, Hans, Kitamura, Hiroshi, Bedke, Jens, Perini, Rodolfo F, Zhang, Pingye, Imai, Kentaro, Willemann-Rogerio, Jaqueline, Quinn, David I, Powles, Thomas

Volltext